Attached files

file filename
8-K - FORM 8-K - LUNA INNOVATIONS INCd350020d8k.htm

Exhibit 99.1

 

LOGO  

Release

Luna Innovations Incorporated

1 Riverside Circle, Suite 400

Roanoke, VA 24016

Luna Innovations Reports First Quarter 2012 Financial Results

Net loss improves 67% from prior year quarter; Total revenues decrease 7% from prior year quarter; Operating expenses decrease 18% from prior year quarter

(ROANOKE, VA, May 9, 2012) – Luna Innovations Incorporated (NASDAQ: LUNA) today announced its financial results for the first quarter ended March 31, 2012.

As compared to the same quarter last year, Luna improved its net loss to $0.3 million for the first quarter of 2012 from a net loss of $1.0 million, as lower operating expenses more than offset a decline in revenues. Total revenues decreased to $8.4 million in the first quarter of 2012 compared to $9.0 million in the first quarter of 2011, primarily due to lower revenues from sales of fiber optic test and measurement equipment. Gross profit decreased to $3.2 million for the first quarter of 2012 compared to $3.3 million for the first quarter of 2011.

Luna also reduced its operating expenses to $3.5 million in the first quarter of 2012 compared to $4.2 million in the first quarter of the prior year. Adjusted EBITDA, a non-GAAP measure, which is earnings before interest, taxes, and non-cash expenses of stock based compensation, depreciation, amortization and warrant expense, improved to $0.5 million for the first quarter of 2012, as compared to $0.3 million for the first quarter of 2011. Cash decreased to $7.9 million at March 31, 2012 from $8.9 million at December 31, 2011.

“We continue to make progress towards achieving the corporate growth strategies that we outlined late last year,” said My Chung, chief executive officer of Luna. “For example, we are focusing our efforts on accelerating product sales in fiber optic sensing through ongoing development of our ODiSi platform. Secondly, we recently announced a new development agreement with Philips Healthcare, which further strengthens our position in the medical field. And finally, we are continuing to advance our cybersecurity solutions. We remain confident that achievement of these strategies will drive long-term growth and increased shareholder value.”

~ MORE ~        


LUNA INNOVATIONS INCORPORATED    Luna Q112 Earnings, Page  2

 

First Quarter Financial and Business Highlights

 

 

Total revenues decreased by 7%, from $9.0 million in the first quarter of 2011 to $8.4 million in the first quarter of 2012.

 

 

Products and licensing revenue decreased by 20%, from $3.4 million in the first quarter of 2011 to $2.7 million in the first quarter of 2012. Technology development revenues increased by 1%, to $5.7 million for the first quarter of 2012 from $5.6 million for the first quarter of 2011.

 

 

Gross profit for the first quarter of 2012 decreased to $3.2 million, or 38% of total revenues, from $3.3 million, or 37% of total revenues, for the corresponding period of 2011.

 

 

Selling, general and administrative expenses decreased by 25% to $2.8 million, or 33% of total revenues for the first quarter of 2012, from $3.7 million, or 41% of total revenues, for the first quarter of 2011. This decrease was attributable to a $0.4 million reduction in our stock compensation expense, a $0.3 million reduction in legal and other professional fees, primarily the result of a threatened proxy contest in 2011, and $0.2 million of consulting fees to Dr. Kent Murphy incurred in the first quarter of 2011 as a result of accelerating expense recognition under our consulting agreement with him.

 

 

Total operating expenses decreased to $3.5 million, or 42% of total revenues, for the first quarter of 2012 from $4.2 million, or 47% of total revenues for the first quarter of 2011.

 

 

Adjusted EBITDA increased to $0.5 million in the first quarter 2012 from $0.3 million in the first quarter of 2011.

 

 

Net loss attributable to common stockholders improved to $0.4 million for the first quarter of 2012 compared to $1.1 million for the first quarter of 2011.

 

 

Cash and cash equivalents totaled $7.9 million at March 31, 2012 as compared to $8.9 million at December 31, 2011.

 

 

Luna extended its development and supply agreement with Intuitive Surgical, as the companies work towards the integration of Luna’s shape and position sensing technology into Intuitive’s medical robotic products.

 

~ MORE ~        


LUNA INNOVATIONS INCORPORATED    Luna Q112 Earnings, Page  3

 

 

Luna was recognized with a U.S. Army Small Business Innovation Research (SBIR) Achievement award for its successful development of high-performance antennas for military vehicles.

 

 

Luna announced a development agreement with Philips Healthcare to conduct work in advancing Luna’s technology towards the commercialization of fiber-optic shape sensing in the non-robotic medical field.

Outlook 2012

Based on information as of May 9, 2012, Luna continues to expect total revenue for 2012 to be in the range of $32.5 million to $37.0 million. Also for 2012, we continue to anticipate a net loss to common stockholders in the range of $0.2 million to $1.2 million. For the second quarter of 2012, we expect revenue of $8.5 million to $9.0 million and a net loss attributable to common stockholders of $0.1 million to $0.3 million.

Non-GAAP Measures

In evaluating the operating performance of its business, Luna’s management excludes certain charges and credits that are required by generally accepted accounting principles (“GAAP”). These non-GAAP results provide useful information to both management and investors by excluding items that the company believes may not be indicative of its operating performance, because either they are unusual and the company does not expect them to recur in the ordinary course of its business or they are unrelated to the ongoing operation of the business in the ordinary course. These non-GAAP measures should be considered in addition to results and guidance prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. The non-GAAP measures included in this press release have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.

Conference Call Information

As previously announced, Luna Innovations will conduct an investor conference call at 5:00 p.m. (EDT) today to discuss its financial results and business developments for the first quarter of 2012 and expectations for the remainder of 2012. The call can be accessed by dialing 866.356.4441 domestically or 617.597.5396 internationally prior to the start of the call. The participant access code is

 

~ MORE ~        


LUNA INNOVATIONS INCORPORATED    Luna Q112 Earnings, Page  4

 

56519917. Investors are advised to dial in at least five minutes prior to the call to register. The conference call will also be webcast live over the Internet. The webcast can be accessed by logging on to the “Investor Relations” section of the Luna Innovations website, www.lunainnovations.com, prior to the event. The webcast will be archived under the “Webcasts and Presentations” section of the Luna Innovations website for at least 30 days following the conference call.

About Luna Innovations:

Luna Innovations Incorporated (www.lunainnovations.com) is focused on sensing and instrumentation. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The company’s products are used to measure, monitor, protect and improve critical processes in the markets it serves. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in Roanoke, Virginia.

Forward-Looking Statements:

The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include our expectations regarding financial results for the second quarter and full year 2012, the company’s focus on accelerating product sales in fiber optic sensing, continuing development of shape sensing technology in the medical area and advancing cybersecurity solutions, demand for the company’s fiber optic equipment and technologies, our expanded relationship with Intuitive Surgical, and our new relationship with Philips Healthcare. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of the company may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation the fact that the outlook for the second quarter of and full year 2012 could change, failure of demand for the company’s products and services to meet expectations, technological challenges, and those risks and uncertainties set forth in the company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at http://www.sec.gov, and at the company’s website at http://www.lunainnovations.com. The statements made in this release are based on information available to the company as of the date of this release and Luna Innovations undertakes no obligation to update any of the forward-looking statements after the date of this release.

 

~ MORE ~        


LUNA INNOVATIONS INCORPORATED    Luna Q112 Earnings, Page  5

 

Luna Innovations Incorporated

Condensed Consolidated Statements of Operations

 

     Three Months Ended March 31,  
     2012     2011  
     (Unaudited)     (Unaudited)  

Revenues:

    

Technology development

   $ 5,659,496      $ 5,621,615   

Products and licensing

     2,713,814        3,377,009   
  

 

 

   

 

 

 

Total

     8,373,310        8,998,624   
  

 

 

   

 

 

 

Cost of revenues:

    

Technology development costs

     3,902,900        4,086,165   

Products and licensing costs

     1,247,494        1,572,691   
  

 

 

   

 

 

 

Total

     5,150,394        5,658,856   
  

 

 

   

 

 

 

Gross Profit

     3,222,916        3,339,768   
  

 

 

   

 

 

 

Operating expense:

    

Selling, general and administrative

     2,800,317        3,725,829   

Research, development, and engineering

     695,155        512,378   
  

 

 

   

 

 

 

Total

     3,495,472        4,238,207   
  

 

 

   

 

 

 

Operating loss

     (272,556     (898,439
  

 

 

   

 

 

 

Other expense, net

    

Other income (expense), net

     23,265        (1,985

Interest expense

     (79,658     (114,423
  

 

 

   

 

 

 

Total

     (56,393     (116,408
  

 

 

   

 

 

 

Loss before income taxes

     (328,949     (1,014,847

Income tax expense

     5,799        10,020   
  

 

 

   

 

 

 

Net loss

     (334,748     (1,024,867

Preferred stock dividend

     34,096        41,628   
  

 

 

   

 

 

 

Net loss attributable to common stockholders

   $ (368,844   $ (1,066,495
  

 

 

   

 

 

 

Net loss per share of common stock:

   $ (0.03   $ (0.08

 

~ MORE ~        


LUNA INNOVATIONS INCORPORATED    Luna Q112 Earnings, Page  6

 

Luna Innovations Incorporated

Condensed Consolidated Balance Sheets

 

     March 31,
2012
    December 31,
2011
 
     (Unaudited)        

Assets

    

Current assets

    

Cash and cash equivalents

   $ 7,879,363      $ 8,939,127   

Accounts receivable, net

     6,824,530        5,958,086   

Inventory, net

     3,273,384        3,330,773   

Prepaid expenses

     930,689        1,071,438   

Other current assets

     36,796        35,717   
  

 

 

   

 

 

 

Total current assets

     18,944,762        19,335,141   

Property and equipment, net

     2,711,445        2,816,674   

Intangible assets, net

     513,656        539,563   

Other assets

     209,252        228,043   
  

 

 

   

 

 

 

Total assets

   $ 22,379,115      $ 22,919,421   
  

 

 

   

 

 

 

Liabilities and stockholders’ equity

    

Current Liabilities

    

Current portion of long term debt obligation

   $ 1,500,000      $ 1,625,000   

Current portion of capital lease obligation

     51,717        50,949   

Accounts payable

     1,649,169        1,656,602   

Accrued liabilities

     3,570,589        3,612,193   

Deferred credits

     1,211,972        1,462,603   
  

 

 

   

 

 

 

Total current liabilities

     7,983,447        8,407,347   

Long-term debt obligation

     3,375,000        3,625,000   

Long-term lease obligation

     169,787        183,008   
  

 

 

   

 

 

 

Total liabilities

     11,528,234        12,215,355   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Preferred stock

     1,322        1,322   

Common stock

     14,063        13,969   

Additional paid-in capital

     59,805,081        59,289,516   

Accumulated deficit

     (48,969,585     (48,600,741
  

 

 

   

 

 

 

Total stockholders’ equity

     10,850,881        10,704,066   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 22,379,115      $ 22,919,421   
  

 

 

   

 

 

 

 

~ MORE ~        


LUNA INNOVATIONS INCORPORATED    Luna Q112 Earnings, Page  7

 

Luna Innovations Incorporated

Condensed Consolidated Statements of Cash Flows

 

     Three months ended March 31,  
     2012     2011  
     (Unaudited)     (Unaudited)  

Cash (used in)/provided by operating activities

    

Net loss

   $ (334,748   $ (1,024,867

Adjustments to reconcile net loss to net cash used in operating activities

    

Depreciation and amortization

     284,101        327,413   

Share-based compensation

     454,584        817,711   

Warrant expense

     11,886        24,041   

Change in assets and liabilities:

    

Accounts receivable

     (866,444     483,634   

Inventory

     57,389        (426,375

Other current assets

     139,670        89,405   

Other assets

     18,791        18,792   

Accounts payable and accrued expenses

     (60,923     (384,997

Deferred credits

     (250,631     684,497   
  

 

 

   

 

 

 

Net cash (used in)/provided by operating activities

     (546,325     609,254   
  

 

 

   

 

 

 

Cash flows used in investing activities

    

Acquisition of property and equipment

     (104,719     (102,221

Intangible property costs

     (48,246     (44,203
  

 

 

   

 

 

 

Net cash used in investing activities

     (152,965     (146,424
  

 

 

   

 

 

 

Cash flows used in financing activities

    

Payments on capital lease obligations

     (12,453     (5,246

Payment of debt obligations

     (375,000     (288,523

Proceeds from exercise of options and warrants

     26,979        132,379   
  

 

 

   

 

 

 

Net cash used in financing activities

     (360,474     (161,390
  

 

 

   

 

 

 

Net change in cash

     (1,059,764     301,440   

Cash and cash equivalents, beginning of period

     8,939,127        7,216,580   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 7,879,363      $ 7,518,020   
  

 

 

   

 

 

 

 

~ MORE ~        


LUNA INNOVATIONS INCORPORATED    Luna Q112 Earnings, Page  8

 

Luna Innovations Incorporated

Reconciliation of EBITDA and Adjusted EBITDA to Net Loss

 

     Three months ended March 31,  
     2012     2011  
     (Unaudited)     (Unaudited)  

Net loss

   $ (334,748   $ (1,024,867

Interest expense

     79,658        114,423   

Taxes

     5,799        10,020   

Depreciation and amortization

     284,101        327,413   
  

 

 

   

 

 

 

EBITDA

     34,810        (573,011

Share-based compensation and warrant expense

     466,470        841,752   

Adjusted EBITDA

   $ 501,280      $ 268,741   
  

 

 

   

 

 

 

###

Investor Contact:

Dale Messick, CFO

Luna Innovations Incorporated

Phone:1.540.769.8400

Email: IR@lunainnovations.com